Is VRTX a good investment in 2026?

Vertex Pharmaceuticals trades at a P/E ratio of 28.5, with medium volatility (27.1% annualized). Recent trend shows weakness.

What is the risk level of VRTX?

Based on 30-day volatility of 27.1%, VRTX has MEDIUM risk. Beta of 0.37 indicates lower sensitivity to market movements than average.

Vertex Pharmaceuticals (VRTX) Stock Analysis & Price Outlook

Q: Does VRTX pay dividends?

Vertex Pharmaceuticals currently does not pay a regular dividend.

Key Metrics

MARKET CAP

$110.97B

P/E RATIO

28.5

BETA

0.37

Less volatile

DIV YIELD

N/A

52W HIGH

$510.77

52W LOW

$362.50

VOLATILITY

27.1%

30d annualized

Price Performance

30-DAY PRICE CHART

$469.34 → $436.27-7.05%

30 days agoToday

1-YEAR PERFORMANCE

$489.10 → $436.27-10.8%

VRTX | 52-week chartLast updated: 4/13/2026

Healthcare Sector Context

Defensive sector including pharmaceuticals, biotech, medical devices, and healthcare services.

METRIC	VRTX	SECTOR AVG	VS SECTOR
P/E Ratio	28.5x	22.0x	↑ 30%
Beta	0.37	0.85	Less volatile
30d Volatility	27.1%	22%	Higher risk

TOP HEALTHCARE PEERS

UNH

JNJ PFPFE

Competitors Analysis

Compare VRTX's key metrics against its main healthcare sector competitors.

COMPANY	PRICE	MARKET CAP	SECTOR
VRVRTX(You are here)	$436.27	$110.97B	Healthcare	—
UNH	$304.33	$276.23B	Healthcare	VIEW →
JNJ	$238.46	$574.66B	Healthcare	VIEW →
PFPFE	$26.92	$153.13B	Healthcare	VIEW →

Click on a competitor to view their full analysis

Technical Analysis

Vertex Pharmaceuticals is currently trading at $436.27, which is 14.6% below its 52-week high. With a beta of 0.37, the stock shows lower sensitivity to market movements.

RSI (14)NEUTRAL

30-DAY TRENDBEARISH

VOLUME1.0M(Below avg)

Frequently Asked Questions

Is VRTX a good buy right now?

Vertex Pharmaceuticals trades at 28.5x earnings. This is near market average. Current risk level is Medium based on 27.1% volatility.

Does VRTX pay dividends?

Vertex Pharmaceuticals does not currently pay a regular dividend. The company may be reinvesting profits for growth.

How volatile is VRTX?

With 30-day annualized volatility of 27.1% and beta of 0.37,VRTX is classified as Medium risk. The stock tends to be more stable than the market average.